Keep up with what's happening in the crypto world in real-time.
All Filters (1)
Some of the altcoins that performed well in the last crypto bull market are still languishing, at a stage that is probably more than halfway through the current bull market. $INJ, $THETA, and $FTM are three altcoins that need to start proving themselves, or face a torrid bear market.
Injective, a leading player in the blockchain space, has unveiled a major partnership with Mercuryo, a renowned provider of fiat on-ramp payment solutions. This strategic alliance is designed to revolutionize how new users enter the Injective ecosystem, making the process of buying digital assets simpler and more accessible than ever before.
The launch of the BUIDL index highlights Injective's capabilities in the decentralized finance and asset tokenization niches.
Mercuryo partners with Injective (INJ)to streamline fiat-to-crypto transactions, easing user onboarding to the Injective ecosystem.
Injective (INJ)collaborates with Mercuryo to streamline user onboarding through a new fiat on-ramp payment solution.
HNTUSD breaks significant resistance $8, jump to $10 possible (Chart of the day) Helium is a decentralized distributed network of Hotspots for Internet of Things (IoT) devices using the LoRaWAN system. It is one of leading DePIN protocol.
Injective (INJ) made headlines with notable achievements that underscore its commitment to growth and innovation. The month saw a significant upgrade to the Injective protocol and the debut of a high-profile event in Brussels, solidifying the platform's position in the competitive blockchain space.
TL;DR Injective has launched the first tokenized index for BlackRock's BUIDL Fund, offering a new level of transparency and accessibility in DeFi. The BUIDL Fund provides institutional investors with access to yields on assets like U.S. treasuries, maintaining a stable value of $1 and offering daily accruing dividends.
Injective blockchain has unveiled a novel tokenized index for BlackRock's USD Institutional Digital Liquidity (BUIDL) Fund. This index enables traders to access the fund through on-chain financial instruments, marking a leap in asset tokenization.
Injective (INJ) is among the top gaining altcoins in the past 24 hours after rising double-digits to test intraday highs of $17.65. These gains see Injective's price third in the top 100 coins by market cap, with Helium (HNT) and the meme coin Dogs (DOGS) outpacing the rest.
This new index market provides unprecedented on-chain access to the BUIDL Fund through innovative financial instruments. This is the first index of its kind that tracks the supply of the BUIDL Fund.
Injective gained bullish momentum on Wednesday, Sept. 4, after a set of consecutive declines over the past two weeks.
With Bitcoin dangling below the $57,000 mark with no clear trend direction, the altcoin market has grown volatile. Amid the increased volatility, the pump and dump in AAVE and a reversal in Injective bring entry opportunities. So, let's look at the price analysis of these DeFi tokens.
Injective (INJ)introduces the first-ever tokenized index for BlackRock's BUIDL Fund, offering innovative on-chain financial instruments to users.
Following a recent slumping market, the crypto prices today have ignited investor curiosity globally. Bitcoin (BTC) price prevented further downside momentum and retained a hold at the $57K price level today.
Injective launched a tokenized index for the BlackRock BUIDL fund, accessible via decentralized applications on its blockchain network.
Injective has introduced a new tokenized index for BlackRock's BUIDL Fund, enabling users to track the fund's supply. According to a statement from Injective (INJ), this index is the first perpetual market of its kind.
The Injective (INJ) community witnessed significant developments in August, including a major chain upgrade and the successful Injective Builder House event in Brussels.
Injective, the popular Cosmos-based blockchain for decentralized finance, continued retreating amid concerns about its ecosystem. Injective (INJ) token retreated to $16.90 on Sep. 3, its lowest point since Aug. 8.
With the market resuming its bearishness today, August 30th, Injective continues to slip and slide. According to CoinGecko, INJ took a nose dive by 16% which slashed any hopes of a short-term recovery.
With the crypto market wilting under the weight of these fearful times, three of the higher end altcoins are at, or near, major support levels once again - is this the time to buy?
AI-space has attracted huge interest in recent times with the token leading the markets with massive gains. Unfortunately, these tokens have been failing to attract buying volume and as a result, the liquidity flow has been to other tokens. Here is what's next for these popular AI tokens.
Injective (INJ) is currently positioned at a critical level after last week's impressive breakout, which saw the token gain over 25% in just seven days. Strong altcoins like Injective are becoming increasingly important to watch in a market characterized by volatility and uncertainty.
Trading at $21.77 as of the latest data, INJ's recent performance is turning heads and fueling speculation about its potential to reach a new all-time high (ATH) of $100. This article explores the factors contributing to INJ's recent gains, examines technical indicators, and assesses the likelihood of reaching the $100 milestone.
